secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000719135-24-000023
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical appoints Stavros Vizirgianakis as Chairman; founder Andrew Makrides retires after 40+ years
--------------------------------------------------------------------------------

- Andrew Makrides retired as Chairman effective May 7, 2024, after serving since 1982.
- Stavros Vizirgianakis appointed Chairman and director to fill vacancy; term expires at 2024 annual meeting.
- Vizirgianakis is a former CEO of Misonix and current director of Xtant Medical and Medinotec.
- Agreement includes standstill until 2025 annual meeting, limiting ownership to 9.9% and requiring vote with Board.
- Board and Vizirgianakis will cooperate to identify an additional director within six months if he holds 5%+ shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/0000719135-24-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/apyx-20240507.htm
  HTML page:      https://secwatch.observer/filing/0000719135-24-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer